コーヴァンスは Labcorp Drug Development になりました

ひとつのグローバルカンパニーとして、数百万もの人々に革新的技術を提供しています。そして、ともに力を合わせ、より高度な医療の飛躍的進歩の実現に向けて前進し続けます。

詳細

オンコロジー & 血液学医療コンサルティングチーム

お問い合わせ

We have a dedicated team of over 50 oncology physicians with an average of 23 years of industry and clinical experience, in countries across Europe, North America, Latin America and Asia. Labcorp physicians’ experience extend from translational/early phase development through product launch, late-phase/post marketing studies. 

コーヴァンスの医療チームメンバーは、臨床、学術分野、業界での経験を吟味して選ばれ、小児腫瘍科を含むほとんどのオンコロジーへの適応に対応しています。

Within this oncology medical team is a specialized team of oncology medical consultants. This team provides expertise in life-cycle management of specific tumor indications including clinical development planning and strategy, establishment of target product profiles, program feasibility, risk assessment, and execution, registries, as well as program- and study-level medical oversight.

彼らの一人ひとりが治験の全行程で豊富な経験をお客様と共有しながら、お客様の大切な治療薬を安全かつ効率的にオンコロジー患者様のもとに届けられるようお手伝いします。

チームのご紹介

Ariel E. Aguiló 医師
シニア医療ディレクター

Ariel Aguiló, MD, Senior Medical Director for Labcorp Clinical Development Services in Buenos Aires, Argentina, is a board-certified oncologist specialized in gastrointestinal tumors. 顧客の医薬品開発プロジェクトにおいて治験の開発・実施に関する専門知識とサポートを提供しており、当社の分散型治験（DCT）の主題専門家を務めています。 Dr. Aguiló performs medical monitoring on assigned projects, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Labcorp.これまで医師、医療アドバイザー、医療ディレクターとして 10 年間、医薬品の研究開発に携わってきました。 Before joining Labcorp, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. Dr. Aguiló began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. He joined Labcorp in November 2019

Ariel Aguilo

Liliana Baila 医師
シニア医療ディレクター

Liliana Baila, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium. 顧客の医薬品開発プロジェクトでは、リードプロジェクト医師として業務にあたります。プロジェクトチームへの医学的 / 科学的サポートの提供、担当プロジェクトの医療および安全性のモニタリングに加え、プロトコル、症例報告用フォーム、その他のデータならびに資料の開発とレビューを担当しています。医師、臨床研究医、医療ディレクターとして 25 年以上の経験があります。 Before joining Labcorp, she served as Clinical Research Physician for the European Organization for Research and Treatment of Cancer (EORTC) in Brussels.ルーマニアの大学病院で、新生児学と小児科を専門とする医師としてキャリアをスタートしました。 She joined Labcorp in June 2020.

Liliana Baila

Maria Ignacia Berraondo 医師
シニア医療ディレクター

Maria Ignacia Berraondo, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Berraondo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcrop. 血液学の分野において、また医療アドバイザーや医師として 10 年以上の経験を持ち、そのうち 6 年間は臨床研究開発ディレクターを務めるなど臨床研究に従事してきました。 Before joining Lbcrop, she served as Medical Director at IQVIA in Buenos Aires. Dr. Berraondo joined Labcrop in July 2020.

Maria Ignacia Berraondo

Stefanella Bortini 博士 / 医師
シニア医療ディレクター

Stefanella Bortini, MD, PhD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Milano, Italy. She contributes to the development of Labcorp policies involving medical, safety and therapeutics, and serves as global lead project physician on assigned projects. Dr. Bortini brings more than 30 years of experience in clinical research to Labcorp. コーヴァンスに加わる前は、ミラノを拠点とする Chiltern International 社のオンコロジー メディカルアフェアーズ​​​​​​​部でシニアディレクターを務めていました。i3Research、PRA International、Pharmacia & Upjohn、Eli Lilly の各社でも数々のポジションを歴任しています。イタリアの医療外科試験審議会（Board of Medical and Surgical Examiners）より認定を受けており、米国の ECFMG Certificate も保持。イタリアのフィレンツェ大学で医学の学位を、ノースウエスタン大学で医用生体工学の博士号を取得しています。 She joined Labcorp in July 2019.

Stefanella Bortini

Jose Daniel Fanjul Fuente 医師
医療ディレクター

Jose Daniel Fanjul Fuente, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. He provides medical and scientific guidance and support to project teams and investigative sites on clients’ drug development projects, and reviews protocols, case report forms, clinical study reports and other data and materials. オンコロジー領域の臨床研究開発において、医師、医療ディレクターとして 10 年以上の経験を持っています。現職の前にはアルゼンチン、ブエノスアイレスの IQVIA および Bristol Myers Squibb でオンコロジー部門の医療ディレクター兼マネージャーを務めました。Bristol Myers Squibb では科学活動を指揮し、オンコロジー治療領域の製品ライン（ニボルマブおよびイピリムマブ）の活性化に貢献。 He joined Labcorp in October 2018.

Jose Daniel Fanjul Fuente 医師 - 医療ディレクター

Begoña de las Heras Garcia 医師
シニア医療ディレクター

Begoña de las Heras Garcia, MD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. She is board certified Medical Oncologist, by La Paz hospital, Madrid, Spain. Begoña joined Labcorp in 2016. 顧客の医薬品開発プロジェクトでプロジェクト医師を務め、プロジェクトチーム / 事業開発チームに医療および科学の専門知識を提供しています。また、オンコロジー TA の医師グループのライン管理も行っています。 She brings more than 20 years of national and international clinical oncology research experience to Labcorp. Before her current position, she served as Executive Medical Officer, Early Phase, for Chiltern in the UK.同じ英国の Eisai 社や、スペインの Pivotal CRO、PharmaMar、AstraZeneca、Bristol-Myers Squibb などでも臨床研究職を歴任しました。 She also, was oncologist consult in several hospitals in Spain, General Yagüe Hospital in Burgos, Ntra Sra. Del Prado Hospital in Talavera de la Reina (Toledo) and La Paz Hospital in Madrid.

Begoña de las Heras Garcia

Brian Hamilton 医師 / 博士
シニア医療ディレクター

Brian Hamilton, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Newton, Massachusetts. He serves as Labcorp Subject Matter Expert for cellular immune-oncology, CAR-T and gene therapy. He also serves as global lead project physician on clients' drug development projects. 小児医療、免疫学、造血幹細胞移植、臨床研究開発の分野において 35 年以上にわたる経験があります。 Before joining Labcorp, he served as Executive Medical Monitor for Chiltern International.Galena Biopharma や AstraZeneca、Onyx Pharmaceuticals、Wyeth Oncology をはじめとする製薬およびバイオテクノロジー企業でも、医療ディレクター、ディレクター医師のほか、規制関連業務、臨床研究の上級職を歴任しています。 Dr. Hamilton joined Labcorp in August 2018.

Brian Hamilton

Konstantin Haradinov 医師
医療ディレクター

Konstantin Haradinov, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Sofia, Bulgaria. He contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as global lead project physician and provides medical and safety monitoring on assigned projects; reviews medical data and provides clinical and medical expertise to project teams and other Labcorp departments, and performs safety trend analyses. Dr. Haradinov has more than 15 years of experience in clinical research as a medical director and physician/oncologist. Before joining Labcorp, he served as Medical Officer, Oncology, for Chiltern International in Sofia, Bulgaria. Dr. Haradinov joined Labcorp in April 2019.

Konstantin Haradinov 医師 - 医療ディレクター

He Huang 医師
シニア医療ディレクター

He Huang is Senior Director, Asia Pacific (APAC) for Labcorp Clinical Development Services, based in Shanghai, China. He brings more than 10 years of experience as a physician and researcher in oncology, respiratory therapy and drug development to Labcorp. Before joining Labcorp, He served as Disease Area Head, Oncology/GI, for Bristol-Myers Squibb in Shanghai. 同じ上海にある AstraZeneca 社でシニアマネージャー、Roche 社でオンコロジー / 消化器担当の医療マネージャーも担当しています。AstraZeneca では「Global Champion and China CEO」賞を受賞しました。 He began career as Medical Oncologist at Affiliated Hospital of Tongji Medical College of Huazhong University of Science and Technology in Wuhan, China. He joined Labcorp in September 2019.

He Huang

Adrianne Kelly 医師
シニア医療ディレクター

Adrianne Kelly, MD, is a Contracted Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey, and Chief Medical Officer of Jude, Peregrine and Kelly Consultants, LLC, in Bethesda, Maryland. 顧客の医薬品開発プロジェクトでは、リードプロジェクト医師として業務にあたります。また、プロトコルや臨床開発計画に対する医学・科学的観点からのフィードバック、プロトコルの要件に照らした治験施設の実施可能性に関するアドバイス、担当プロジェクトの医療監視、プロジェクトチームへのトレーニングを提供します。血液学 / オンコロジー領域の医師、臨床研究者、医薬品開発者として 30 年以上の経験を有しています。ジョージタウン大学で医学の学位を取得。さらに、医療分野におけるリーダーシップや学業成績に関して十数以上の賞を受賞しています。 Dr. Kelly joined Labcrop in August 2010.

Adrianne Kelly, MD Senior Medical Director

Geoffrey Kannan 博士 / 医師
シニア医療ディレクター

Geoffrey Kannan, PhD, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Labcorp Clinical Development Services, based in Princeton, New Jersey. 顧客の医薬品開発プロジェクトでグローバルリード医師を務め、医療の専門知識を提供しながら治験の開発・運営をサポートしています。 Dr. Kannan brings more than 10 years of experience as a physician and medical director to Labcorp, specializing in oncology and pediatrics. Before joining Labcorp, he practiced as Pediatric Hematologist/Oncologist and Pediatric Neuro-oncologist, affiliated with Children's National Medical Center.それ以前は、ダナ・ファーバー癌研究所、ボストン小児病院、ハーバード大学医学部の小児神経腫瘍科で、小児科および小児神経腫瘍科の指導医を務めました。 The author or co-author of many peer-reviewed journal articles, presentations and abstracts, Dr. Kannan joined Labcorp in November 2018.

Geoffrey Kannan

Carlo Lanza 医師 / 博士
医務執行責任者

Carlo Lanza, MD, PhD, is Executive Medical Officer for Labcorp Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase 1-4 clinical trials for Labcorp clients. また、標的療法、低分子、バイオロジックス、遺伝子治療の初期開発とトレンスレーショナルリサーチの非臨床プログラムを指揮するほか、 後期開発戦略の策定や、登録に関するプログラムの作成・承認も監督します。医師、医療ディレクターとして 20年以上臨床研究開発に携わってきており、小児疾患とオンコロジーを専門としています。 Before joining Labcorp, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. Dr. Lanza has also held leadership positions with Novartis Oncology, Pfizer Global R&D, and AstraZeneca UK. Carlo joined Labcorp in 2012.

Carlo Lanza

Wojciech Massalski 医師
医療ディレクター

Wojciech Massalski, MD, is Medical Director for Labcorp Clinical Development Services, based in Maidenhead, United Kingdom. 顧客のプロジェクトでグローバルリードプロジェクト医師を務め、医療の専門知識を提供しながら治験の開発・実施をサポートしています。具体的には、治験実施施設の実施可能性評価、被験者のリクルート、担当プロジェクトにおける実施可能性・リスク評価およびデータ安全性モニタリングの実施などを行います。 Dr. Massalski has more than 20 years of experience as a physician, clinical researcher and medical director. Before Labcorp, he was Senior Medical Officer for Chiltern International in the UK. また、同じく英国の Pfizer および Synexus Limited では臨床研究や医療モニタリングに従事しました。 Dr. Massalski joined Labcorp in April 2019.

Maria Mateo 医師
シニア医療ディレクター

Maria Mateo, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Mateo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcorp. 医師、臨床研究者、医療ディレクターとして 30 年以上の経験を持ち、これまでに AMGEN、Boehringer Ingelheim、IQVIA、IVAX Argentina、Syneos Health、Bristol-Myers Squibb のほか、他の医薬品開発 / ヘルスケア企業でさまざまな職務を歴任しました。 Dr. Mateo joined Labcorp in November 2020.

Maria Mateo

Valery Novikov 医学博士
シニア医療ディレクター

Valery Novikov, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Paris, France. She is responsible for the medical strategy and execution of clients' clinical research projects. プロトコル、症例報告書、治験報告書、新薬申請書、検査値、有害事象、データ表、その他のデータや資料のレビュー、 ならびに担当プロジェクトの医療・安全性モニタリングを行います。 She brings more than 20 years of national and international clinical research experience to Labcorp. Before joining Labcorp, Dr. Novikov served as Clinical Study Director for Sanofi in France. He has also held clinical research positions with Generium, Helios Clinical Research, and PRA International in Moscow, Russia. Dr. Novikov joined Labcorp in August 2019.

Valery Novikov 医師 / 博士 - シニア医療ディレクター

Martine Poelman 医師
Executive Medical Director

Martine Poelman is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Labcorp clients. Martine brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Labcorp. Before assuming her current position, Martine served more than 15 years as Global Head of Oncology Research for Labcorp, providing medical monitoring for more than 200 clinical trials. Before joining Labcorp, she served as Clinical Research Physician, Hemato-Oncology-Infectiology, for Eli Lilly in Brussels. 研究職に転身する前は、オランダのウィルヘルミナ小児病院で小児腫瘍科の骨髄移植、血液腫瘍専門医として勤務しました。 Martine joined Labcorp in November 1996.

Martine Poelman

Chia Portera 医学博士
シニア医療ディレクター

Chia Portera, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey. She evaluates and establishes drug development strategies for clients' clinical research projects and provides scientific/clinical expertise to project teams. また、プロトコル、治験報告書、新薬申請、その他データや書類の開発、評価、修正、ならびに担当プロジェクトの医療・安全性モニタリングに携わります。臨床研究・開発分野において、腫瘍内科医および医療ディレクターとして 10 年以上の経験を有しています。 As a medical director at Genentech before joining Labcorp, Dr. Portera led clinical development strategies of post-market therapies for treatment of HER2+ breast cancer. She joined Labcorp in July 2015.

Chia Portera

Kamal Veer Singh Saini 医師
Executive Medical Director

Kamal Veer Singh Saini, MD, is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium. 英国の医師免許を持つ認定腫瘍内科医でもあります。 He contributes to the scientific strategic leadership of the Oncology area at Labcorp, and provides clinical and medical expertise to project teams and other Labcorp departments on clients' drug development projects. Kamal brings more than 15 years of experience in clinical research and development to Labcorp. He previously served as Associate Scientific Director for an academic research organization and as Medical Advisor, Institute Jules Bordet, Brussels. The author or co-author of several peer-reviewed journal articles, Kamal joined Labcorp in June 2015.

Kamal Veer Singh Saini

Ivana Teodorovic 医師
シニア医療ディレクター

Ivana Teodorovic, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Labcorp clients. 具体的な業務には、プロトコルの策定、審査、修正、そして医療モニタリング、患者様データの評価などが含まれます。医師、医療ディレクターとして医薬品の研究開発で 30年以上の経験を持ち合わせています。 Before joining Labcorp, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy.Teodorovic 医師は、セルビア、ベオグラードの腫瘍学・放射線学研究所で認定解剖病理学者としてキャリアを開始しています。 She joined Labcorp in May 2005.

Ivana Teodorovic

Laura Vidal 医師
Executive Medical Director

Laura Vidal, MD, is Executive Medical Director for Labcorp Clinical Development Services, based in Madrid, Spain. Dr. Vidal is the Medical Head of the Oncology group in EU. She contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as point of contact for key clients on business oversight; manages relationships with investigators/sites for clinical trials, and mentors clinical research physicians and medical directors across the company. 医師、臨床癌専門医、医療ディレクターとして 15 年以上の経験があります。 Before joining Labcorp, she was Executive Medical Director for Syneos Health in Madrid, and previously served as a physician, medical oncologist, and clinical trials coordinator for a hospital in Barcelona.多数の査読付き学術論文の著者および共著者でもあり、受賞した健康や研究関連の賞は相当数にのぼります。 She joined Labcorp in December 2020.

Laura Vidal

Ronald Walls, MD, MBA
シニア医療ディレクター

Ronald Walls, MD, MBA, is Senior Medical Director, Global Clinical Development, based in Princeton, New Jersey. He provides medical and safety monitoring on client projects, reviews medical data, and develops and reviews protocols, case report forms and other materials. Dr. Walls has more than 20 years of experience in the biopharma industry, holding positions of increasing responsibility at many top biopharmaceutical companies. Dr. Walls is the founder of The Alliance of Minority Medical Associations and was appointed by former President George W. Bush as Chair of Secretary of Health and Human Services Tommy Thompson's Roundtable for Disparities Affecting Men of Color. A much-requested speaker and subject matter expert on how to increase the accrual and retention of minority patients and physicians in industry-sponsored clinical research, he joined in March 2021.

Ronald Walls, MD, MBA, is Senior Medical Director, Global Clinical Development,

Liang Wan 医学博士
医療ディレクター

Liang Wan, MD, PhD, is Medical Director for Labcorp Clinical Development Services in Shanghai, China. He serves as lead project physician on clients' drug development projects, provides medical/scientific expertise to project teams, reviews protocols and medical data, and is responsible for medical and safety monitoring on assigned projects. オンコロジー、消化器病学、血液学の分野での治療経験があり、医師、臨床研究医、医療ディレクターとして 25 年以上の経験があります。 Before joining Labcorp, he was Medical Director for IQVIA in Shanghai, serving as Global or Regional Medical Advisor on assigned projects.上海交通大学瑞金病院の外科医および臨床責任医師としてキャリアをスタートしました。 Dr. Wan joined Labcorp in May 2019.

Liang Wan

Howard Yeh 医師
シニア医療ディレクター

Howard Yeh 医師はニュージャージー州プリンストンを拠点とするシニア医療ディレクターです。お客様への医療 / 科学サービスの代表として、プロジェクト提案に関わる実現可能性のディスカッションに参加し、お客様との関係や、治験の責任医師および施設との関係を築き、お客様の医薬品開発プロジェクトにおいてリードプロジェクト医師を務めます。臨床研究と医薬品開発の医療ディレクターとして 15 年以上にわたる経験を有しています。 Before joining Labcorp, he was Medical Director for Johnson and Johnson, Janssen Oncology Clinical Development Services, in Pennsylvania.カリフォルニア州の Amgen Clinical Development Services でも医療ディレクターを務めた経歴があります。 The author or co-author of nearly two dozen peer-reviewed journal articles, Dr. Yeh joined Labcorp in May 2016.

Howard Yeh, MD Senior Medical Director

吉川麗月医学博士
シニア医療ディレクター

Reigetsu Yoshikawa, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services in Osaka, Japan. She contributes to the development of medical strategies and execution of clients' clinical programs and provides medical/scientific expertise to project teams. Dr. Yoshikawa has more than 30 years of experience as a physician, medical director/advisor, and professor of medicine in Japan. Before joining Labcorp, she was Senior Medical Advisor for Eli Lilly and previously served as Senior Medical Lead for Dainippon Sumitomo Pharma in Japan. Dr. Yoshikawa has served on the editorial boards of several peer-reviewed journals and has authored or co-authored dozens of articles, presentations, and abstracts. She joined Labcorp in January 2021.

Reigetsu Yoshikawa
セクションメニュー

つながる

シェア

お問い合わせはこちら

お問い合わせ
コーヴァンス ロゴ

ラボコープは世界をリードするライフサイエンス企業として、製薬、医療技術、農作物保護、化学品の各業界向けに開発業務受託および開発サービスを提供しています。

ナビゲーション
スクロールして上に戻る